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Abstract 
Chytridiomycosis is an amphibian skin disease that threatens amphibian 
biodiversity worldwide.  The infectious fungal agent of chytridiomycosis, 
Batrachochytrium dendrobatidis, can affect amphibians differently in that some 
amphibian populations can co-exist with the fungus and others quickly succumb to 
disease.  Amphibians in populations that co-exist with the B. dendrobatidis are shown to 
have sub-lethal infections on their skins.  Several co-existing populations have also been 
shown to have higher proportions of individuals with antifungal skin bacteria suggesting 
the role of skin bacteria in disease outcome.  Little is known about the mechanism(s) that 
antifungal skin bacteria use to ameliorate the effects of B. dendrobatidis.  In this study I 
identified that a B. dendrobatidis isolate JEL 310 zoospores (motile infectious phase) 
displays chemotaxis in the presence of two bacterially-produced metabolites (2,4-
diacetylphloroglucinol and indole-3-carboxaldehyde).  In the presence of either 
metabolite, B. dendrobatidis (JEL 310) zoospores are more likely to move away from the 
metabolites.  Another B. dendrobatidis isolate JEL 423 did not display chemotaxis in the 
presence of violacein (bacterially-produced metabolite).  Using parameters estimated 
from my B. dendrobatidis chemotaxis study, a mathematical model illustrates that B. 
dendrobatidis JEL 310 zoospores will disperse onto the source containing no metabolite 
if zoospores initially start both away from the source and on the source.  The model 
illustrates that in the presence of a bacterially-produced 2,4-DAPG, B. dendrobatidis JEL 
310 zoospores will disperse away from the source.  These results suggest that amphibians 
that have skin bacteria that produce 2,4-DAPG might be able to keep B. dendrobatidis 
infections below the lethal threshold and thus be able to co-exist with the fungus. 
 
 
 
 
 
 
 
Introduction 
 Chytridiomycosis is an amphibian skin disease caused by the fungus 
Batrachochytrium dendrobatidis (Longcore et al. 1999).  The disease causes amphibian 
declines and extinctions all over the world (Bosch et al. 2001, Carey et al. 2003, IUCN 
2006, Rachowicz et al. 2006, Skerrat et al. 2007).  Interestingly, B. dendrobatidis affects 
amphibian populations differently even within the same species.  There are some 
amphibian populations that co-exist with B. dendrobatidis with sub-lethal infections and 
other populations (even of the same amphibian species) that decline within 1-2 years to 
extinction (Davidson et al. 2003, Hanselmann et al. 2004, Retallick et al. 2004).   
 Once a single B. dendrobatidis zoospore (the motile infectious phase) infects 
amphibian skin, B. dendrobatidis grows exponentially on the skin (Carey et al. 2006).  
Carey et al. (2006) suggest the number of B. dendrobatidis needed to cause mortality 
must surpass the lethality-threshold.  Many amphibian populations that co-exist with B. 
dendrobatidis are shown to have small numbers of B. dendrobatidis on frog skins 
compared to populations to go extinct.  Low numbers of B. dendrobatidis on frog skins 
results in sub-lethal infections. One explanation for this may be differences in amphibian 
defenses present in populations such as amphibian skin bacteria. 
Many bacterial species can be isolated from amphibian skins (Becker et al. 2009, 
Harris et al. 2006, Harris et al. 2009a, Harris et al. 2009b, Lam et al. 2010, Lauer et al. 
2007, Lauer et al. 2008, Woodhams et al. 2007a, Woodhams et al. 2007b).  Some of these 
bacteria produce antifungal metabolites that are inhibitory to B. dendrobatidis.  There are 
three hypothesized mechanisms that amphibian skin bacteria use to reduce the number of 
B. dendrobatidis zoospores (its motile pathogenic phase): 1) skin bacteria may reduce the 
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number of available attachment sites on amphibian skin, 2) antifungal metabolites 
produced by skin bacteria may directly kill B. dendrobatidis, and 3) skin bacteria may 
alter B. dendrobatidis zoospore behavior resulting in chemotaxis away from bacterially-
produced antifungal metabolites.  For my thesis research, I have chosen to focus on the 
third hypothesis. 
The objective of this study was to investigate B. dendrobatidis behavior response 
to antifungal metabolites produced by skin bacteria through its movement.  Disease 
transmission may be a function of behavior movement response of B. dendrobatidis.  
Measuring the response of the pathogen in the presence of different concentrations of 
antifungal metabolites may allow an improved understanding of the transmission 
(infection) and re-infection of B. dendrobatidis.  From these measurements I estimated 
parameters for a mathematical model used to illustrate how fast a B. dendrobatidis 
zoospore will reach an amphibian with bacterially-produced metabolites on its skin.  I 
also used these estimated parameters to illustrate how zoospores will disperse onto an 
amphibian with metabolites present on its skin.  Below, I will briefly review emerging 
infectious diseases, amphibian declines, chytridiomycosis, and published research about 
the amphibian innate immune system that protects against the pathogen. 
 
Emerging Infectious Disease (EIDs)  
Over the past two decades there have been a number of emerging infectious 
diseases (EIDs), both human and wildlife, that are of concern, and the frequency of 
emergence of novel EIDs is increasing (Acevedo-Whitehouse and Duffus 2009, Dazak et 
al. 2000).  The increased frequency of the emergence of novel EIDs is believed to be a 
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result of changes in the environment and human encroachment.  Jones et al. (2008) 
analyzed the origins of 335 EIDs between the years 1940 and 2004.  They found that the 
origins of EIDs are significantly correlated with socio-economic, environmental, and 
ecological factors.  For example, coral bleaching has increased dramatically during the 
last few decades.  The incidences of coral bleaching are highly correlated with increased 
sea-water temperature.  At high summer sea-water temperatures, Vibrio shiloi expresses 
virulence genes for adhesion.  These genes allow the bacterium to displace the normal 
microbiota, adhere to the coral mucus, and penetrate the coral epidermis where it 
produces toxins that lead to disease (Rosenberg and Ben-Haim 2002).  
Emerging infectious diseases pose a threat to global biodiversity.  Daszak et al. 
(2000) argue that EIDs threaten biodiversity by depopulating host populations and 
causing chronic population depression.  The geographic spread of chytridiomycosis, an 
EID plaguing amphibians worldwide, greatly threatens amphibian biodiversity.  Its global 
distribution and high virulence as well as other factors influencing amphibian declines are 
real concerns for amphibian conservation. 
 
Amphibian Crisis 
 It has been estimated that at least a third of amphibians worldwide are threatened 
with extinction (Briggs et al. 2005, Lips et al. 2008, Moore and Church 2008, Rachowicz 
et al. 2006, Stuart et al. 2004) (Figure 1).  Amphibian declines and extinction are only a 
part of what is being called the sixth mass extinction, which includes other vertebrate and 
invertebrate classes (Wake and Vredenburg 2008).  The cause of amphibian declines is 
hypothesized to be due to a synergy of habitat destruction, exotic predators, competition 
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with non-native species, pollution, utilization as food and pets (Blaustein and Wake 1990, 
Fisher and Garner 2007, Stuart et al. 2004), effects of climate change (Lips et al. 2008, 
Pounds and Crump 1994), increased levels of ultraviolet radiation (Blaustein et al. 1995), 
and disease (Carey and Alexander 2003; Pounds and Crump 1994; Pounds et al. 2006).  
 
 
 
Although it is argued that deforestation and habitat loss are the major factors in 
amphibian declines, Stuart et al. (2004) listed 207 amphibian declines that they reported 
as “enigmatic”.  These amphibian declines were reported in pristine areas such as natural 
parks and areas unaffected by deforestation.  Skerratt et al. (2007) demonstrated that the 
presence of an EID, chytridiomycosis, is the primary cause of these enigmatic declines.  
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Chytridiomycosis has contributed to declines in pristine areas and is responsible for 
amphibian extinctions on all continents where amphibians are found (Bosch et al. 2001, 
Carey et al. 2003, IUCN 2006, Rachowicz et al. 2006, Skerrat et al. 2007).  The major 
factors of amphibian declines such as habitat loss and now the emergence of 
chytridiomycosis in areas unaffected by habitat loss leave amphibians extremely 
susceptible to extinction. 
 
Chytridiomycosis 
 Chytridiomycosis was first documented in 1998 as the cause of declines of 
amphibians in Australia and Central America (Berger et al. 1999).  In 1999, Longcore et 
al. reported that the agent of chytridiomycosis is a fungus which they named 
Batrachochytrium dendrobatidis, a zoosporic chytrid fungus that is the only known 
chytrid to parasitise vertebrates; however there are many other species of chytrid that 
parasitise plants (Sharma 2004).  This pathogen has dimorphic life history: (1) a motile 
zoospore stage (the infective phase) and (2) a stationary zoosporangium stage (growing 
phase) (Berger et al. 2005a).  The fungus has been documented to expand its range as an 
advancing wave (Berger et al. 1999, Lips et al. 2005, Lips et al. 2008, Moore and Church 
2008).   
The emergence of B. dendrobatidis is not well understood and the two opposing 
hypotheses that attempt to explain the emergence of this amphibian disease are the novel 
pathogen hypothesis and the endemic pathogen hypothesis (Carey and Alexander 2003, 
Pounds and Crump 1994, Pounds et al. 2006, Kilpatrick et al. 2010).  In support of the 
novel pathogen hypothesis is the genetic similarity between isolates of B. dendrobatidis 
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found worldwide (James et al. 2009, Morehouse et al. 2003).  The little variation found 
among isolates from different continents suggest that B. dendrobatidis has been 
introduced from a source population into different areas of the world and spread rapidly 
throughout.  Support for the endemic pathogen hypothesis would entail that the levels of 
genetic variation observed from isolates would show more genetic divergence.  There is 
some evidence that chytridiomycosis outbreaks are correlated with increased 
temperatures and thus may contribute to the pathogen becoming endemic.  This evidence 
provides some support for the endemic pathogen hypothesis, which states that B. 
dendrobatidis has been historically endemic and conditions are changing to favor its 
pathogenesis.  Pounds et al. (2006) correlated outbreaks of chytridiomycosis and global 
warming by analyzing the time at which an outbreak occurred and changes in sea surface 
and air temperatures.  Changes in global temperature may act as a stress mechanism for 
amphibians and cause changes in the immune system, making amphibians more 
susceptible to disease (Davidson et al. 2007, Raffel et al. 2006) or these changes may 
favor the life-cycle of B. dendrobatidis.  It is possible the B. dendrobatidis has been 
recently introduced into various parts of the world and that changing climatic conditions 
facilitates its emergence.  Thus, both hypotheses may be correct to some degree. 
The infective stage of B. dendrobatidis attacks the keratinized cutaneous layer of 
post-metamorphic amphibians and the keratinized jaw sheaths and tooth rows of larvae 
(Rachowicz and Vredenburg 2004, Rachowicz et al. 2006).  Infection occurs most often 
on the ventral surface of the amphibian, but severe infections can spread over the entire 
body of the amphibian (Berger et al. 2005a, Pessier et al. 1999).  During infection, 
hyperkeratosis (an overproduction of keratin in the epidermis) is observed and, in deeper 
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regions of the epidermis, hyperplasia (abnormal proliferation of cells) is common and the 
epidermis will begin to slough (Berger et al. 1998, Berger et al. 2005a, Longcore et al. 
1999).  Behavioral changes are often observed in infected individuals such as anorexia, 
lethargy, unresponsiveness to stimuli, the inability of the amphibian to right itself (Berger 
et al. 2005b, Nichols et al. 2001), and infected individuals are sometimes observed trying 
to dry themselves by lifting their limbs into the air or moving away from water sources 
(Becker and Harris 2010). 
Little is understood about the mode of mortality chytridiomycosis causes, but it is 
hypothesized that B. dendrobatidis causes death in two ways: (1) B. dendrobatidis may 
release a deadly toxin that diffuses into the blood stream (although to date, none have of 
been found), and (2) B. dendrobatidis disrupts osmotic and ionic balances of the 
amphibian due to hyperkeratosis and hyperplasia (Berger et al. 1998, Berger et al. 2005a, 
Carey et al. 2003, Voyles et al. 2007, Voyles et al. 2009).  Disruption of osmotic and 
ionic balances has been documented to cause cardiac distress and failure in post-
metamorphic amphibians (Voyles et al. 2009).  Mortality is documented primarily in 
post-metamorphic amphibians, but can also occur in larvae (Blaustein et al. 2005). 
A single zoospore has the capability of establishing infection due to exponential 
growth of the pathogen observed on amphibian skin.  Carey et al. (2006) show that one 
zoospore was able to cause morbidity and mortality in the boreal toad, Bufo boreas.  
When a single zoospore comes in contact with an amphibian it begins to form a 
zoosporangium and produces more zoospores within the zoosporangium that are later 
released.  These released zoospores have the capability to re-infect the amphibian or be 
transmitted to a new host (Rachowicz et al. 2006).  Carey et al. (2006) also demonstrated 
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that B. dendrobatidis zoospore numbers on toad skins had to surpass a threshold of 107-
108 zoosporangia per toad in order to cause mortality of B. boreas. 
Moss et al. (2008) recently found that during the motile zoospore stage, B. 
dendrobatidis displays chemotactic ability to respond with positive movement towards 
hydrolyzed casein (known to support B. dendrobatidis growth), gelatin hydrolysate (a 
constituent of the culture media used for B. dendrobatidis), and cysteine (an abundant 
amino acid of keratin found in epidermal cells of amphibian skin).  Their findings suggest 
that the pathogen is capable of responding to keratin in amphibian skin and can use 
chemotaxis as a method to detect the amphibian host.  Once a single zoospore detects and 
comes in contact with a susceptible amphibian host, exponential growth can quickly 
surpass a lethality-threshold resulting in mortality. 
What is very intriguing about this disease is that not all amphibian species decline 
to extinction and some species are able to co-exist with the fungal pathogen (Davidson et 
al. 2003, Hanselmann et al. 2004, Retallick et al. 2004).  Even more intriguing is that the 
same is true within some amphibian species, where some populations are able to co-exist 
and other populations of the same species drastically decline to extinction.  For example, 
Rana sierrae, the mountain yellow-legged frog of the Sierra Nevada Mountains in 
California, USA has some populations of R. sierrae that have been co-existing with B. 
dendrobatidis for >6 years and other populations that go extinct within 1-2 years after the 
pathogen first emerges (Lam et al. 2010, Rollin-Smith et al. 2006, Woodhams et al. 
2007b).  A better understanding of differences between populations that co-exist with the 
pathogen and populations that go extinct due to the pathogen such as differences in 
amphibian defenses is strongly needed.  Differences in amphibian defenses may lead to 
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insights into finding a more environmentally friendly way to stop the spread of the 
disease and allow for the re-introduction of captive frogs from survival assurance 
colonies. 
 
Amphibian Defenses Against Chytridiomycosis 
 There is considerable variation in amphibian species’ and populations’ response 
to chytridiomycosis (Lips et al. 2005); this may be due to variation in the virulence of B. 
dendrobatidis isolates (Berger et al. 2005b, Retallick and Miera 2007), although 
preliminary data show that there is little genomic variation among B. dendrobatidis 
isolates sampled (James et al. 2009, Morehouse et al. 2003).  Another source of variation 
may be differences in the types and magnitude of immune defenses the amphibian is able 
to mount against the pathogen. 
 There are two major components of the immune system: (1) the adaptive immune 
system and (2) the innate immune system.  Although it has been found that amphibians 
do elicit an adaptive immune response to B. dendrobatidis by producing antibodies, there 
is no published evidence that this response produces protection or immunity (Berger et al. 
2002).  A possible explanation for the inadequacy of the adaptive immune response is 
that the response is “too little, too late”.  The response does not occur in time to prevent 
the mortality from the disease.  Another possibility is that the antibodies are inadequately 
delivered to the infection due to thickened epidermis.  A third possibility is that B. 
dendrobatidis is turning off the amphibians’ immune system.  Recent work shows that 
infected amphibians’ adaptive immune system loci are either not up regulated or are 
down regulated (Rosenblum et al. 2009). 
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The innate immune system is the first line of defense against B. dendrobatidis and 
has several components that are capable of providing protection for the amphibian.  There 
are three known components of the innate immune system that may give amphibians 
protection from B. dendrobatidis: (1) the epidermis as a barrier, (2) antimicrobial 
peptides the amphibian produces, and (3) antifungal symbiotic bacteria that lives on 
amphibian skin (although some researchers may be uncomfortable calling symbiotic 
bacteria part of the innate immune system). 
Research to investigate how the epidermis as a barrier may protect against 
chytridiomycosis has not been explored.  It is possible that amphibians with thick 
epidermal layers may have better protection against the pathogen.  Also, variation in the 
components of mucus secretions and differences in the thickness of the mucus layer may 
also provide explanations for the varying degree of susceptibility in different amphibian 
species to the B. dendrobatidis.  Mucus can protect amphibians from both bacterial and 
fungal pathogens (Fontana et al. 2006).  Fontana et al. (2006) describe a new gland 
named mucus-producing granular glands (MPGGs) that produce mucus in specialized 
granular glands.  MPGGs produce acidic mucus relative to neutral mucus produced in 
mucous glands.  They hypothesize that neutral and acidic mucus may form two layers of 
mucus that consists of a thin, watery neutral mucus layer with a thicker acidic layer 
underneath.  More research would be necessary to understand how the epidermis as a 
barrier and the mucus layer are involved in the susceptibility of amphibians to 
chytridiomycosis. 
 Antimicrobial peptides (AMPs) are the best studied of the three components of 
the amphibian innate immune system (Davidson et al. 2007, Rollins-Smith et al. 2002, 
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Woodhams et al. 2007a).  These peptides are produced and stored in granular glands in 
the dermis of amphibian skin and found predominately on the dorsal surface of the 
amphibian.  They are released in response to stimulation from the sympathetic nervous 
system (Mills and Prum 1984).  AMPs have been documented as having inhibitory 
activity against bacteria, viruses, including HIV (VanCompernolle et al. 2005), protozoa, 
and fungi (Rinaldi 2002, Zasloff 2002).  Many of these peptides have shown inhibitory 
activity in vitro against B. dendrobatidis (Davidson et al. 2007, Rollins-Smith et al. 2002, 
Rollins-Smith et al. 2005, Rollins-Smith et al. 2006).  Amiche et al. (1999) suggest that 
each species has a unique set of AMPs.  Among individuals, these peptides may vary in 
the density and concentration in which they occur on amphibian skin and the variety of 
AMPs present at any given time (Tennessen et al. 2009).  Woodhams et al. (2007a) 
performed laboratory experiments with four Australian amphibian species in which 
survival rate in vivo and, in a separate experiment, the in vitro effectiveness of the AMPs 
produced by each species were studied.  They experimentally infected the frogs with the 
pathogen and observed survival rate.  The more effective the species’ AMPs were against 
B. dendrobatidis in vitro, the higher the species’ survival rate.  However, factors such as 
environmental change, pesticides, and continual exposure to the pathogen may minimize 
the effectiveness of AMPs produced by amphibians (Davidson et al. 2007, Rollins-Smith 
et al. 2002, Rollins-Smith et al. 2006).  These factors may influence the production of 
AMPs as well their depletion.  For example, pesticides may block chemical signals that 
result in the amphibian’s capabilities to produce a particular AMP although no evidence 
of this exists in the literature. 
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 A less studied component of the innate immune system is the symbiotic bacteria 
that reside on amphibian skin.  Amphibian skin provides a seemingly ideal habitat for 
microorganism colonization in that it is moist and nutrient-rich (Guirard and Snell 1962).  
Bettin and Greven (1986) demonstrated that amphibian skin is colonized by bacteria and 
by their presence suggest that these bacteria are somewhat resistant to the antimicrobial 
peptides the amphibian produced.  Their discovery suggests that some species of bacteria 
may have co-evolved to be resistant to the AMPs found on the amphibian species they 
inhabit.  
 Relationships between commensal bacteria and eukaryotic organisms often occur 
in nature and often these bacteria protect their hosts from pathogens.  Symbiotic bacteria 
that protect organisms from fungi have been identified in Caribbean shrimp, Palaemon 
macrodactylus (Gil-Turnes et al. 1989), pea aphids, Acyrthosiphon pisum (Scarborouch et 
al. 2005), the four-toed salamander, Hemidactylium scutatum (Banning et al. 2008, Lauer 
et al. 2008), the eastern red back salamander, Plethodon cinereus (Becker et al. 2009, 
Harris et al. 2006, Harris et al. 2009b, Lauer et al. 2007, Lauer et al. 2008) and the 
mountain yellow-legged frog, Rana sierrae (Lam et al. 2010, Harris et al. 2009a, 
Woodhams 2007b). 
 In 2006, Harris et al. identified 10 genera of bacteria isolated from the skins of the 
eastern red-backed salamander, Plethodon cinereus, and the four-toed salamander, 
Hemidactylium scutatum, that displayed antifungal activity against B. dendrobatidis in 
vitro.  They first isolated bacteria from the salamander skins and then challenged the 
bacteria against B. dendrobatidis in vitro.  They discovered that some of the bacteria 
produced a zone of inhibition around the pathogen suggesting antifungal activity. 
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More recently, it has been found in field surveys that populations of Rana sierrae 
that co-exist with B. dendrobatidis have higher proportions of individuals with anti-B. 
dendrobatidis skin bacteria than populations that are found to go extinct due to the 
pathogen (Lam et al. 2010, Woodhams et al. 2007b).  In the initial field study, 
Woodhams et al. (2007b) show that a population where B. dendrobatidis had recently 
emerged and that was predicted to go extinct (due to the history of populations in the 
same area) had a low proportion of individuals with at least one anti-B. dendrobatidis 
skin bacterial species relative to another population persisting with B. dendrobatidis.  The 
population with a low proportion of individuals with protective skin bacteria went extinct 
the following year.  An extension of the Woodhams et al. (2007b) field study shows that 
a R. sierrae population with a higher proportion of individuals with anti-B. dendrobatidis 
bacteria survived the arrival of B. dendrobatidis even though it was in an area where 
historically all populations declined to extinction after the emergence of the pathogen. 
Lam et al. (2010) performed a field survey on a R. sierrae population before the 
emergence of the pathogen.  This population was predicted to go extinct due to historical 
field surveys where all populations in the same geographical field location became 
extinct 1-2 years after the arrival of B. dendrobatidis (Vance Vredenburg, personal 
communication).  The pathogen emerged in this population a year after the initial field 
survey, and two years later the population is still found to be surviving and endemic with 
B. dendrobatidis. These field surveys suggest a threshold proportion of individuals need 
anti-B. dendrobatidis bacteria in order for the population to co-exist with the fungus 
(Figure 2).  This is analogous to herd immunity in which only a proportion of the herd or 
population needs to be immunized in order to establish protection from a pathogen for the 
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entire population (Gonclaves 2008).  These studies suggest that approximately 80% of 
individuals need to have anti-B. dendrobatidis protective skin bacteria for co-existence 
with B. dendrobatidis to occur and suggests that the basic reproductive number, Ro, of B. 
dendrobatidis is less than 5 (Lam et al. 2010).  These studies suggest that future 
bioaugmentation treatment would only need to include a proportion of the population 
instead of the whole population. 
These field studies are consistent with the hypothesis that populations with higher 
proportions of individuals with anti-B. dendrobatidis bacteria can co-exist with the 
fungus.  Although the survival of populations with a high percentage of individuals with 
anti-B. dendrobatidis does not prove the hypothesis, it does strengthen it and indicates 
that more research is merited.  Another interesting result from these R. sierrae field 
surveys is that the populations that co-exist do so with a significantly lower density of B. 
dendrobatidis zoospores on their skins than the populations that went extinct (Woodhams 
et al. 2007b) (Figure 3).  This also suggests that there may be a threshold of zoospores 
needed to cause mortality of the amphibian (Carey et al. 2006) and that populations that 
co-exist with B. dendrobatidis do so with sub-lethal infections.  The higher proportion of 
individuals with anti-B. dendrobatidis bacteria correlated with individuals that have sub-
lethal infections suggests that skin bacteria plays a role in driving B. dendrobatidis 
densities down and below lethality-threshold. 
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Several anti-B. dendrobatidis bacterial isolates have been found to produce 
antifungal metabolites that are capable of inhibiting B. dendrobatidis in vitro (Brucker et 
al. 2008a, Brucker et al. 2008b).  Harris et al. (2009b) show that the addition of 
Pseudomonas reactants, a previously identified bacterium found to inhibit B. 
dendrobatidis, to the eastern red-backed salamander, Plethodon cinereus, ameliorated the 
effects of chytridiomycosis.  The salamanders that were bathed with and colonized by P. 
reactants lost less weight, a symptom of chytridiomycosis, than salamanders exposed 
only to B. dendrobatidis.  Harris et al. (2009a) also show that the addition of 
Janthinobacterium lividum, another bacterium found to be anti-B. dendrobatidis, to Rana 
sierrae juveniles prevented the colonization of B. dendrobatidis and had lasting positive 
  
16 
effects for 140 days.  The frogs that were bathed in and colonized with J. lividum were 
also found to have violacein, an antifungal metabolite produced by J. lividum (Brucker et 
al. 2008b), on their skins, suggesting that bio-augmentation of J. lividum increased 
violacein concentration on the skins of R. sierrae.  These studies, in conjunction with 
field surveys, strongly suggest that bio-augmenting a population to have a higher 
proportion of individuals with anti-B. dendrobatidis skin bacteria may be a feasible tool 
to controlling the pathogen in wildlife.  If there is a threshold proportion of individuals 
needed to protect the entire population, not all of the individuals would need to be treated 
(this is analogous to herd-immunity).  
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Understanding the Relationship Between B. dendrobatidis and the Innate Immune 
System by Modeling 
The conservation implications for using anti-B. dendrobatidis bacteria in nature 
need to be further researched.  For example, interactions of symbiotic bacteria and AMPs 
are likely to influence the success of the application of anti-B. dendrobatidis skin bacteria 
to an amphibian population that may result in the protection from the pathogen.  
However, field studies and experiments to study the interactions of these components of 
the innate immune system and the pathogen may be complicated and costly to study in 
vivo.  There are many uncontrollable interactions that may complicate designing a plan to 
conserve amphibian species.  Mathematically modeling this dynamic system is one 
feasible method to further studying this system. 
Two recent mathematical models of B. dendrobatidis and its host have been 
unable to predict co-existence between amphibians and B. dendrobatidis despite using a 
variety of parameter values (Briggs et al. 2005, Mitchell 2008).  The Briggs et al. (2005) 
model could not explain the differences between populations of R. sierrae co-existing 
with B. dendrobatidis and those that declined to extinction by differences in transmission 
rate of B. dendrobatidis, susceptibility, infectiousness, or population size.  Their model 
only predicted one of two outcomes; there was either extinction of the amphibian host or 
extinction of the pathogen.  One criticism of this model and possible explanation for the 
models inability to predict co-existence may be the lack of a re-infection parameter, 
which is the proportion of B. dendrobatidis zoospores that re-infects its host.  The model 
proposed by Mitchell et al. (2008) model could only predict the co-existence of the toad, 
Bufo bufo, if the model incorporated saprobic reproduction of B. dendrobatidis (which 
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has not been observed) for a few B. bufo generations.  However, eventually B. bufo went 
extinct as B. dendrobatidis density increased.  This model also does not include a re-
infection parameter, but assumes that all juvenile toads that were infected with the fungus 
left the population and died. 
A re-infection parameter of the amphibian host is needed to reflect the biology of 
B. dendrobatidis.  As mentioned earlier, B. dendrobatidis has the capability to re-infect 
its host and, thus, causes exponential growth of zoospores on amphibian skin.  However, 
Woodhams et al. (2007b) found that populations of R. sierrae that were co-existing with 
B. dendrobatidis had significantly lower averages of zoospores on frog skins and that 
these populations had higher proportions of individuals with anti-B. dendrobatidis skin 
bacteria.  This suggests that the role of amphibian defenses is to lower the re-infection 
parameter of B. dendrobatidis and control the growth of zoospores on amphibian skins 
which may result in co-existence of the amphibian and fungus. 
 
Study System 
For my thesis I have investigated the motile zoospore life-stage of B. 
dendrobatidis in the presence and absence of metabolites produced by known amphibian 
skin bacteria to further investigate the role of these metabolites in transmission (infection) 
and re-infection.  As proposed by Moss et al (2008), B. dendrobatidis posses chemotaxis 
in the presence of constituents of its food source.  I have expanded this idea to investigate 
if B. dendrobatidis is also chemotactic in the presence of metabolites that display anti-B. 
dendrobatidis properties.  Although known concentrations of bacterially-produced 
metabolites on amphibian skin are poorly estimated due to small sample size and few 
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species studied, it is hypothesized that concentrations are most likely variable and 
unevenly dispersed on amphibian skin.  This is due to the idea that some 
microenvironments (Figure 4A-D) on amphibian skin would attract high concentrations 
of bacterial growth (such as mucus glands) and other microenvironments would attract 
low concentrations of bacterial growth (such as granular glands that produce AMPs 
active against bacteria). 
 
Figure 4.  Three different types of microenvironments (A-C) found on amphibian skin that 
would determine different amounts and composition of bacterial growth.  The mucus gland 
(A) is surrounded by a thicker mucus layer and has several different bacteria species 
surrounding the gland.  The granular gland (B) is distinguished from the mucus gland by a 
gradient of AMPs (shown in red) and would only attract bacteria species that are AMP 
tolerant.  Small pores (C) along the epidermis would attract different bacteria and possibly 
create anaerobic environments.  Bacteria are shown to inhabit both the surface layer of the 
epidermis as well as in the mucus layer itself.  An illustration with all three 
microenvironments is shown by D. 
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To study chemotaxis of B. dendrobatidis zoospores, I followed individual 
zoospore movement away and towards metabolites produced by amphibian skin bacteria. 
 
Metabolites Produced by Anti-B. dendrobatidis Skin Bacteria 
 I investigated three metabolites produced by known amphibian skin bacteria that 
show inhibitory activity against B. dendrobatidis.  These three metabolites were chosen 
based on their known anti-B. dendrobatidis properties and availability.  These 
metabolites have all been identified from skin bacteria isolated from amphibian skins. 
 
 The metabolite 2,4-diacetylphloroglucinol (2,4-DAPG) has antiviral, antibacterial, 
antifungal, antihelminthic, and phytotoxic properties (Weller et al. 2007) (Figure 5).  This 
metabolite has been identified in several species of Pseudomonas and is a known 
protector against many root and seedling diseases (Weller et al. 2007).  It was first shown 
to have anti-B. dendrobatidis properties when identified from Lysobacter gummosus 
isolated from the skins of amphibians (Brucker et al. 2008a).  The anti-B. dendrobatidis 
bacterium has been identified on the eastern red-backed salamander, Plethodon cinereus, 
and the four-toed salamander, Hemidactylium scutatum (Harris et al. 2006).  Using a 96-
well inhibitory growth assay, Brucker et al. (2008a) determined that 2,4-DAPG has 
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inhibitory properties against B. dendrobatidis (IC50=8.73µM, MIC=136.13µM) although 
the mechanisms of this inhibition are unknown. 
 Two other anti-B. dendrobatidis metabolites identified from amphibian skin 
bacteria used during this experiment are indole-3-carboxaldehyde (I3C) and violacein 
(Figure 5).  These metabolites were identified from the bacterium Janthinobacterium 
lividum (Brucker et al. 2008b) that has been cultured from the skins of the salamander P. 
cinereus (Harris et al. 2006) and from the skins of the frogs Rana muscosa (Woodhams et 
al. 2007b) and Rana sierrae (Lam et al. 2010).  The metabolite I3C is more commonly 
known as a hydrolysis product found in the plant family Cruciferae and for its anti-
tumorgenesis properties (Anderton et al. 2004, Chohan et al. 2010), but has also been 
identified in several bacteria species (Brucker et al. 2008b, Gutierrez-Lugo et al. 2005).  
I3C was also shown to be inhibitory against B. dendrobatidis using 96-well inhibition 
assays (IC50= 0.13µM; MIC=68.9µM) (Brucker et al. 2008b).  Brucker et al. (2008b) 
found on one wild caught P. cinereus a I3C concentration of 51µM, but a larger sample 
size is needed to confirm I3C concentration on amphibian skin.  Violacein is a dark violet 
pigment that was first identified to be produced by Chromobacterium violaceum (Liu and 
Nizet 2009), which is a close relative to J. lividum.  It has been shown to have strong 
antioxidant properties and has the capacity to induce apoptosis (Liu and Nizet 2009).  
Violacein has been identified with antifungal (Becker et al. 2009, Brucker et al. 2008b), 
antibacterial, antiprotozoan (Liu and Nizet 2009), antiviral, and antitumorgenesis 
(Antonisamy and Ignacimuthu 2010).  Brucker et al. (2008b) identified that violacein was 
inhibitory against B. dendrobatidis using a 96-well inhibition assay (MIC=1.8µM).  They 
also identified that there appears to be a threshold concentration of violacein needed to 
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inhibit B. dendrobatidis in vitro.  Becker et al. (2009) determined that the concentration 
of violacein on the skins of P. cinereus that was protective against B. dendrobatidis was 
approximately 18µM and Brucker et al. (2008b) found concentrations of violacein on 
three naturally caught P. cinereus to be 207µM, 10µM, and 4µM respectively. 
 For this study I used these three metabolites at inhibitory concentration of 50% 
(IC50) and minimum inhibitory concentration (MIC) with the exception of violacein.  
Since there was no identified IC50 with violacein, I used the concentration of violacein 
found to be protective against B. dendrobatidis determined on the salamander P. 
cinereus.  Natural concentrations of these metabolites found on amphibian skins needs to 
be researched more with larger sample sizes and with more than one amphibian species. 
 
The Role of Chemotaxis of B. dendrobatidis in its Transmission and Re-Infection 
To investigate how chemotaxis can influence transmission and re-infection of B. 
dendrobatidis, I mathematically illustrated zoospore movement using a random walk on a 
simple lattice with parameters gathered from my three metabolite investigations.  With 
this model I illustrate that if a zoospore is in water near an amphibian is it more likely 
that the zoospore will move towards the amphibian (initial infection) or away 
(transmission) depending on the metabolite concentration present on the amphibian.  
Likewise, I illustrate that a zoospore on the amphibian skin is more likely to move 
towards the amphibian (re-infection) or away from that amphibian to infect a susceptible 
host (transmission) dependant on metabolite concentration present on the already infected 
amphibian. 
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This model can be important in understanding the lethality-threshold of B. 
dendrobatidis and can provide insights in developing mathematical models that include 
re-infection parameters as well as varying proportions of populations that have anti-B. 
dendrobatidis bacteria on amphibian skins.  If metabolite concentrations on amphibian 
skins are high they may provide the amphibian with protection from B. dendrobatidis by 
encouraging zoospores to move away and not colonize.  This may lead to zoospores 
moving towards amphibians without anti-B. dendrobatidis bacteria.  This could quickly 
cause mortality of susceptible amphibians if a large number of zoospores move towards it 
and if zoospore density surpasses the lethality-threshold (Carey et al. 2006).  Likewise 
this model may also predict that if metabolite concentrations are present on the 
amphibian but not high enough to provide complete protection from B. dendrobatidis 
through mortality of the pathogen, then it may be possible to maintain B. dendrobatidis 
infections below mortality threshold resulting in the endemic populations of amphibians. 
 
 
Methods 
Maintaining Batrachochytrium dendrobatidis Cultures 
 Two isolates of B. dendrobatidis, JEL 310 and JEL 423, used for this project were 
received from Dr. Joyce Longcore at the University of Maine.  Isolate JEL 310 was 
isolated from the frog species Smilisca phaeota from Fortuna, Panama by P. Murphy and 
had been cultured from -80oC frozen stock for approximately a year before the beginning 
of this experiment. The isolate JEL 310 has been shown to have morbidity and mortality 
effects on Plethodon cinereus (Becker et al. 2009).  The isolate JEL 423 was isolated 
from the frog species Phyllomedusa lemur that was collected during a die-off in Panama 
and had been cultured from -80oC frozen stock approximately one month before the 
beginning of its use.   
Stock cultures were serially transferred on a weekly basis for both JEL 310 and 
JEL 423.  Both isolates of B. dendrobatidis were maintained in 1% tryptone broth and 
stored at 23oC.  Each week 1mL of culture was transferred to a fresh stock of tryptone 
broth. 
Additional stock cultures containing antibiotics were serially transferred on a 
monthly schedule.  Both isolates of B. dendrobatidis were maintained in 1% tryptone 
broth + 50µL of penicillin (100mg/mL) and streptomycin sulfate (200mg/mL) each.  
Cultures were allotted a week of growth at 23oC and then stored at 4oC for approximately 
a month.  Each month 1mL of the culture was transferred to fresh antibiotic broth.  These 
cultures were maintained in the event that stock cultures maintained on a weekly basis in 
the absence of antibiotics were compromised.  In the event new weekly cultures were 
needed, 1mL of the monthly stock that contained antibiotics was transferred to fresh 1% 
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tryptone broth and allowed to grow one week before another transfer to 1% tryptone 
broth.  After two serial transfers into fresh 1% tryptone, isolates were then used for 
experimentation to ensure that there were no effects from being maintained in antibiotics. 
 
Harvesting B. dendrobatidis Zoospores 
 In order to harvest B. dendrobatidis zoospores, 1mL of weekly B. dendrobatidis 
stock was transferred to a 1% agar + 1% tryptone plate and evenly spread on the entire 
surface of the plate.  Plates were allotted time to just dry (approximately 5-10 minutes), 
covered and sealed, and placed at 23oC for approximately 3-5 days.  After 3-5 days of 
growth, plates were observed under a compound microscope at 200x to confer active 
zoospores. 
 Plates that had activity were then flooded with 3mL of sterile Provosoli medium 
(Wyngaard and Chinnappa, 1982) for 20 minutes to stimulate B. dendrobatidis 
zoosporangia to release zoospores.  Another 1mL of Provosoli medium was added to the 
plates and gently “swished” around the plate to bath the zoosporangium.  All standing 
liquid containing the released zoospores was then gently removed off of the plate using a 
pipette and stored in 15mL Falcon tubes. 
 Active zoospores, defined as actively moving, were then counted using a standard 
hemocytometer slide.  To reach target densities of approximately 450-500 active 
zoospores/100µL Provosoli medium, active zoospore broths were either concentrated or 
diluted accordingly. 
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Customized Microscope Slides 
 Standard glass microscopes slides were fashioned with eight 1cm x 1cm chambers 
using 100% Silicone Aquarium Sealant (All-Glass Aquarium Co., Inc., Franklin, WI) 
(Figure 6).  These chambers were made by hand using a standard grid.  The silicone was 
given at least 12 hours to set while in a sterile, closed container. 
 
 
  
 
 
Immediately before an experiment 40µL of substrate was plated along the left 
edge of each chamber.  The experimental treatments were: 1% agar + 1% tryptone 
(control) and 1% agar + 1% tryptone with one of the following: 68.89µL indole-3-
carboxaldehyde (I3C) (minimum inhibitory concentration (MIC)), 136.13µL 2,4-
diacetylphloroglucinol (2,4,-DAPG), which is the MIC (2,4-DAPG high), 8.73µL 2,4-
DAPG, which is the IC50 (2,4-DAPG low), 1.8µL violacein, which is the MIC 
(violacein low), and 18µL violacein (violacein high) (Table 1).  For all metabolites with 
Figure 6.  Customized microscope slide with 8 
chambers approximately 1cm x 1 cm made out 
of 100% Silicone Aquarium Sealant. 
  
27 
the exception of violacein the B. dendrobatidis isolate JEL 310 was studied.  The change 
in isolate use was due to the mortality of isolate JEL 310 and the exhaustion of available 
replacements.  The B. dendrobatidis isolate JEL 423 was used to study chemotaxis in the 
presence and absence of violacein.  Substrates were given a few minutes to polymerize 
before a solution of 450-500 active zoospores of B. dendrobatidis per 100µL Provosoli 
medium was added to a chamber.  Vaseline was added around the silicone chambers to 
ensure there was sealing between all chambers and a 24 x 60 mm plastic microscope 
cover slip was used to seal top of chambers. 
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Data Collection of Zoospore Movement 
 Chambers were observed at two times: initial time (t = 0) and 6 hours at 200x 
using a Nikon eclipse TE2000 inverted microscope.  Sampling time was determined by 
calculating the proportion of B. dendrobatidis zoospores that were still active every hour 
for 12 hours.  This was done by randomly sampling ten 100µm x 100µm grids using a 
random number generator and calculating the average proportion of active zoospores for 
each hour.   Sampling time was determined to be initial time (t = 0) and the time where 
approximately 50% of B. dendrobatidis isolate 310 zoospores remained active.  The 
substrate was sometimes placed to appear on the left and other times to appear on the 
right to account for any effects due to light. Data were collected by taking 50 still-frame 
photos over a 10 second period (approximately every 0.2 seconds) taken with a Roper 
Scientific CoolSnap HQ monochrome digital camera focused at the center width of the 
chambers at approximately the center depth along the edge of the substrate and of interest 
area (Figure 7).  These images were collected using Roper Scientific Image Capture 
Software (Roper Scientific, Germany). 
 Zoospore movement was collected by haphazardly selecting 5 zoospores from 
each of the three distances away from the edge of the substrate at both t = 0 hours and t = 
6 hours.  The distances used were 0-100µm, 200-300µm, and 500-600µm.  To put this in 
context, the far end of the silicone was 5000µm.  Each selected zoospore was followed 
throughout each still-frame for 10 seconds.  At each transition between still-frames, 
which was approximately every 0.2 seconds, the movement of the zoospore either 
towards the substrate, no movement, or away from the substrate was recorded.   
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 Initial distance of the zoospore to the edge of the agar source (agar/Provosoli 
interface) was also recorded.  After collecting movement data, end point distance of the 
zoospore to the edge of the agar source was also recorded.  Total distance moved by a 
zoospore over 10 seconds was calculated. 
 
 
 
 The number of active zoospores was counted at both 0-100µm and 500-600µm 
distances away from the substrate and compared between t = 0 hours and t = 6 hours. 
Figure 7. A schematic of the 3D area within a chamber that was used for sampling B. 
dendrobatidis zoospore movement.  The camera was focused in the center of the 
substrate at central depth along the edge of the substrate and area where suspended 
zoospores were plated.  The 3D box in the figure represents the substrate. 
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Statistics 
 Zoospore movement data were statistically analyzed to determine if moment 
towards substrate and away from substrate was a function of time, location, and treatment 
using ANOVA.  The number of movements made towards and away from the substrate 
was analyzed only.  The no movement variable was not analyzed since it was determined 
by the other two variables.  Each data point used for statistical analysis was an average of 
all zoospores recorded within a time, location and treatment combination.  The averaging 
procedure eliminated the possibility of “pseudo-replication” because the responses of 
potentially interacting zoospores within a chamber were averaged.  This left the level of 
replication as five, which was the number of chambers used for each treatment.  In 
addition, according to the central limit theorem those means should approach a normal 
distribution.  If time and location were found to not have a significant effect on 
movement towards substrate and away from substrate, they were pooled together and 
tested using a one-way ANOVA to determine the effect of treatment.   
 The number of active zoospores at two locations (0-100um and 500-600um) and 
at two time points (t = 0 and 6 hours) were compared using ANOVA.  If location had no 
effect on the number of active zoospores then these data were pooled. 
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Mathematical Model 
 
 A random walk on a simple lattice was modeled with a system of difference 
equations describing B. dendrobatidis zoospore movement away from or towards a 
source (S) depending on its starting distance from the source.  The source represents the 
1% agar + 1% tryptone (control) or 1% agar + 1% tryptone + metabolite (experimental).  
The following nine boxes represent an increasing distance away from the source (S).  
Since we will later find location was found to have no effect on zoospore movement, the 
probability of a zoospore moves to the left (ρL) or to the right (ρR) during the time 
increment of 10 seconds are the same no matter what location the zoospore is in.  A 
schematic of the model is shown in Figure 8 and a full set of equations is given as 
follows: 
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 The model was implemented stochastically to illustrate how many steps a single 
zoospore would take to reach the source.  A direct simulation was created to simulate 
zoospores moving on a lattice in order to measure the number of steps a zoospore took to 
reach the source.  This model was simulated 500 times once for each treatment with one 
zoospore at starting position farthest away from the source using a probability matrix.  
The mathematical equations (1.1-1.10) describe the probability for a single zoospore to 
be at a certain location after t time steps.  Simulations then describe a zoospores random 
movement along the lattice using the described probabilities given by equations 1.1-1.10.  
The number of movements it took for a zoospore to reach the source was recorded and 
the weighted average for each treatment was found. 
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The model was also implemented deterministically to illustrate the dispersal of 
zoospores if their starting position is at the middle of the model (D5).  The overall 
distribution was then tracked as a function of time and recorded.  This model was 
performed for each treatment once with 200 zoospores beginning at D5.  The model was 
stopped at six different time steps: initial time step where all 200 zoospores start at D5 
and every 10 time steps until 50 times steps are reached.  The number of zoospores at 
each position was recorded and the weighted average for each treatment was found. 
The mathematical software Sage® (www.sagemath.org) was used to implement 
all models.  Zoospores with a starting position farthest away from the source would 
correspond to zoospores at a mucus/pond interface and would simulate zoospores that 
would be transmitted from either pond water or from an infected amphibian.  Zoospores 
starting on the source (S) would be similar to zoospores released to the surface of the 
epidermis that could re-infect. 
 
Parameter Estimation 
 Parameters are fully defined with estimated values from my experiment in Table 
2.  Each parameter was estimated by finding the probability of a zoospore moving 
towards or away from the source.  Since location was found to not have an effect on 
zoospore movement, the probabilities for a zoospore moving from each box either 
towards or away from the source is the equal for all distances.  
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Results 
Description of Batrachochytrium dendrobatidis Zoospore Movement Patterns 
 Both isolates of B. dendrobatidis, JEL 310 and JEL 423, displayed several 
patterns of zoospore movement (Figure 9A-D).  These movement patterns were observed 
in all treatments including the control, and there were no distinguishing movement 
patterns that were typical to an experimental treatment.  Zoospores typically were seen to 
move in circular patterns (Figure 9A) or were seen oscillating inwards or outwards 
(Figure 9B).  Less often, zoospores were seen to display linear movement either with 
direction (Figure 9C) or without direction (Figure 9D) in a seemingly random nature.  
Linear non-directional movement was observed to be the most rare pattern of zoospore 
movement. 
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Determining Sampling Times 
 Sampling times were determined to be initial time (t = 0) and the time at which 
50% of B. dendrobatidis zoospores remained active for isolate JEL 310 (Figure 10A) (n = 
3).  This isolate chosen was initially to be used for the entire experiment.  Approximately 
50% of zoospores remained active up to 6 hours after harvest and by the twelfth hour the 
vast majority of zoospores were no longer active.  When observed at 24 hours, 
zoosporangium could be seen suggesting that inactive zoospores were not dead but 
Figure 9.  These are movement patterns observed by B. dendrobatidis 
zoospores (JEL 310 and 423) in all treatments including the control.  
Patterns most frequently observed were circular (A) and inward/outward 
oscillations (B).  Less commonly, zoospores were also seen to move 
linearly with direction (C) or without direction (D). 
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transition life stage.  Activity was also measured for isolate JEL 423 (Figure 10B) where 
by the twelfth hour approximately 75% of zoospores remained active (n = 3). 
 
 
 
 
 
 
 Synopsis of Results 
 Zoospores from isolate JEL 310 moved toward the source less in both 2,4-DAPG 
low and 2,4-DAPG high treatments than the control treatment, but not the I3C treatment.  
For all treatments (2,4-DAPG low, 2,4-DAPG high, and I3C), zoospores from isolate JEL 
310 moved away from the metabolite more than the control treatment.  The mathematical 
Figure 10.  Zoospore activity for B. dendrobatidis isolates JEL 310 (A)  (n = 3) 
and JEL 423 (B) (n = 3).  Sampling times were determined to be initial (t = 0) and 
where 50% of JEL 310 zoospores remained active (~t = 6). 
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models predicted that zoospores would reach the source in the control treatment faster 
than zoospores in 2,4-DAPG low, 2,4-DAPG high, and I3C treatments and that more 
zoospores would distribute onto the source in the control than all three treatments. 
There was no difference in the number of movements zoospores from isolate JEL 
423 made either toward or away from both violacein low and violacein high compared to 
the control treatment.  The mathematical models predicted that zoospores in the control, 
violacein low, and violacein high would all reach the source at approximately the same 
time and that zoospores would distribute equally in the violacein high and control 
treatment.  Less zoospores would distribute on the source in the violacein low treatment 
compared to violacein high and control treatments. 
 
B. dendrobatidis (JEL 310)  Zoospore Movement Toward and Away from the Source 
 
 Within treatment comparisons 
 There was no overall significant effect of time (t = 0 hours versus t = 6 hours) on 
zoospore movement patterns and total distance a zoospore moved towards or away from 
the source during a 10 second time period within any of the treatments (Table 3).  Time 
had no effect on zoospore movement towards the source within the control, 2,4-DAPG 
low, 2,4-DAPG high, and I3C treatments (Table 3).  Time had no effect on zoospore 
movement away from the source within the control, 2,4-DAPG low, 2,4-DAPG high, and 
I3C treatments (Table 3).  Time also had no effect on total distance a zoospore moved 
during a ten second period of time within the control, 2,4-DAPG low, 2,4-DAPG high, 
and I3C treatments (Table 3).  Since there was no effect of time on zoospore movement 
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either towards or away from the source or on total distance a zoospore moved these data 
were pooled together. 
 
Table 3.  The effect of time on B. dendrobatidis (JEL 310) movement within treatment 
comparisons towards and away from the source and total distance a zoospore moved 
within a time period. 
ANOVA 
Movement towards the source 
Treatment n’s df F Sig. 
Control 10 28 0.24 0.0639 
2,4-DAPG low 10 28 0.02 0.8994 
2,4-DAPG high 10 28 0.82 0.3731 
I3C 6 18 0.10 0.7206 
Movement away from the source 
Treatment n’s df F Sig. 
Control 10 28 3.77 0.1262 
2,4-DAPG low 10 28 0.47 0.4943 
2,4-DAPG high 10 28 0.03 0.8573 
I3C 6 18 0.10 0.7590 
Total distance a zoospore moved during a 10 sec. period 
Treatment n’s df F Sig. 
Control 10 28 0.24 0.6302 
2,4-DAPG low 10 28 3.08 0.7223 
2,4-DAPG high 10 28 0.53 0.4733 
I3C 6 18 1.79 0.9516 
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 Location (0-100µm, 200-300µm, and 500-600µm) had no effect on zoospore 
movement towards the source within the control, 2,4-DAPG low, and I3C treatments 
(Table 4). Zoospores moved more towards the metabolite as location from the source 
increased within the 2,4-DAPG high treatment (P = 0.0025) (Table 4) (Figure 11A). 
Location had no effect on zoospore movement away from the source within the 
control, 2,4-DAPG low, and I3C treatments (Table 4).  Zoospores moved away from the 
metabolite less frequently as location from the source increased within the 2,4-DAPG 
high treatment (P = 0.0200) (Table 4) (Figure 11 B).  
 Sampling location did not have a significant effect on zoospore total movement 
over a ten second period of time within the control, 2,4-DAPG low, and I3C treatments 
(Table 4).  There was an effect of location on zoospore total movement within the 2,4-
DAPG high treatment, where zoospores moved further away from the metabolite at 
sampling locations 0-100µm and 200-300µm than zoospores sampled at 500-600µm (P = 
0.0001).  Locations were pooled for all treatments, including 2,4-DAPG high, since the 
overall trend was for the response variables to not vary as a function of location. 
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Table 4.  The effect of location on B. dendrobatidis  (JEL 310) movement within 
treatment comparisons towards and away from the source and total distance a zoospore 
moved within a time period. 
ANOVA 
Movement towards the source 
Treatment n’s df F Sig. 
Control 10 27 0.05 0.9540 
2,4-DAPG low 10 27 2.57 0.9720 
2,4-DAPG high 10 27 7.79 0.0025 
I3C 6 15 1.46 0.2707 
Movement away from the source 
Treatment n’s df F Sig. 
Control 10 27 0.02 0.9777 
2,4-DAPG low 10 27 0.86 0.4346 
2,4-DAPG high 10 27 4.62 0.0200 
I3C 6 15 0.50 0.6202 
Total distance a zoospore moved during a 10 sec. period 
Treatment n’s df F Sig. 
Control 10 27 0.50 0.6150 
2,4-DAPG low 10 27 3.08 0.0645 
2,4-DAPG high 10 27 7.79 0.0001 
I3C 6 15 1.79 0.2088 
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Between treatment comparisons 
Movement towards the source 
Treatment had a significant effect on zoospore movement towards the source.  
Zoospores in the control moved towards the source significantly more than 2,4-DAPG at 
low and high treatments (P < 0.0001) (Table 5) (Figure 12A).  Both 2,4-DAPG low and 
high treatments were grouped together and apart from the control treatment as determined 
Figure 11.  Average B. dendrobatidis (JEL 310) zoospore movement 
over two time periods (0 and 6 hours) toward the source (A) and away 
from the source (B) for control (n’s = 10), I3C (n’s = 6), 2,4-DAPG 
low (n’s = 10), and 2,4-DAPG high (n’s = 10) respectively at each 
sampling location.  Location only had a significant effect on 2,4-DAPG 
high both towards the metabolite (P = 0.0025) and away from the 
metabolite (P = 0.0200).  Letters above the graphs represent Tukey 
groupings for 2,4-DAPG high. 
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by Tukey groupings.  There was no significant effect on zoospore movement towards the 
source between the control and I3C treatments although there was a trend for lower 
number of movements towards the I3C treatment (Table 5).   
 
Movement away from the source 
The treatments 2,4-DAPG low, 2,4-DAPG high, and I3C had a higher number of 
moves away from the source containing the metabolite relative to the control that 
contained no metabolite (Figure 12B).  Zoospores moved away from the source that 
contained both 2,4-DAPG at low and high treatments more frequently than the control 
group (P = 0.0086) (Table 5).  Zoospores also moved away from the source that 
contained I3C more frequently than the control group (P = 0.0149) (Table 5).   
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Table 5.  Between treatment comparisons of B. dendrobatidis (JEL 310) movement 
towards and away from the source. 
ANOVA 
Movement towards the source 
Treatments n’s df F Sig. 
Control, 2,4-
DAPG low, & 
2,4-DAPG high 
30 87 11.16 <0.0001 
Control & I3C 30, 18 46 3.18 0.0812 
Movement away from the source 
Treatments n’s df F Sig. 
Control, 2,4-
DAPG low, and 
2,4-DAPG high 
30 87 5.04 0.0086 
Control and 
I3C 
30, 18 46 6.40 0.0149 
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Figure 12.  Average B. dendrobatidis (JEL 310) zoospore movement over sampling 
location and time toward the source (A) and away from the source (B) for control (n = 
30), 2,4-DAPG low (n = 30), 2,4-DAPG high (n = 30), and I3C (n = 18) respectively.  
Both 2,4-DAPG low and high treatments moved towards the source less than the 
control (P < 0.0001) and away from the source more relative to the control (P = 
0.0086).  Zoospores in the I3C treatment did not move away from the source more 
than the control (P = 0.0812), but did move away from the source more relative to the 
control (P = 0.0149).  Asterisk above points are significantly different from the control 
and error bars represent standard error. 
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B. dendrobatidis (JEL 423)  Zoospore Movement Toward and Away from the Source 
 B. dendrobatidis (JEL 423) zoospore movement data were only collected for 
initial time (t = 0 hours).  It was determined from the results using isolate 310 that time 
had no effect on zoospore movement either towards or away from the source or on total 
zoospore movement for a ten second period of time relative to t = 6 hours.  Therefore, t = 
6 hours was not sampled. 
 
 Within treatment comparisons 
 Location (0-100µm, 200-300µm, and 500-600µm) had no effect on zoospore 
movement towards the source within the control, violacein low, and violacein high 
treatments (Table 6).  Location also had no effect on zoospore movement away from the 
source within the control, violacein low, and violacein high (Table 6).  During a period of 
ten seconds, location had no effect on total zoospore movement towards or away from the 
source within the control, violacein low, and violacein high (Table 6).  These data were 
then pooled together. 
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Table 6.  The effect of location on B. dendrobatidis (JEL 423) movement within 
treatment comparisons towards and away from the source and total distance a zoospore 
moved within a time period. 
ANOVA 
Movement towards the source 
Treatment n’s df F Sig. 
Control 5 12 0.50 0.6196 
Violacein low 5 12 1.52 0.2575 
Violacein high 5 12 0.25 0.7810 
Movement away from the source 
Treatment n’s df F Sig. 
Control 5 12 0.30 0.7475 
Violacein low 5 12 0.01 0.9867 
Violacein high 5 12 2.67 0.1100 
Total distance a zoospore moved during a 10 sec. period 
Treatment n’s df F Sig. 
Control 5 12 1.32 0.3041 
Violacein low 5 12 0.72 0.5075 
Violacein high 5 12 2.17 0.1565 
 
 
Between treatment comparisons 
 The control and both violacein low and high concentration had approximately 
equal movements both towards and away from the source (Table 7) (Figure 13A-B).  
Treatment also had no effect on total distance a zoospore moved towards or away from 
the source among the control and both violacein low and high treatments (Table 7). 
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Table 7.  Between treatment comparisons of B. dendrobatidis (JEL 423) movement 
towards and away from the source and total movement of a zoospore during a time 
period. 
ANOVA 
Movement towards the source 
Treatments n’s df F Sig. 
Control, 
violacein low, 
& violacein 
high 
15 42 0.44 0.6470 
Movement away from the source  
Treatments n’s df F Sig. 
Control, 
violacein low, 
& violacein 
high 
15 42 0.71 0.5005 
Total distance a zoospore moved during a 10 sec. period 
Treatments n’s df F Sig. 
Control, 
violacein low, 
& violacein 
high 
15 42 0.07 0.9287 
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B. dendrobatidis (JEL 310) Zoospore Activity 
 
 Within treatment comparisons 
 More zoospores were active at t = 0 hours than t = 6 hours within the control (P < 
0.0001), 2,4-DAPG low (P < 0.0001), 2,4-DAPG high (P = 0.0003), and I3C (P = 
0.0002) treatments (Table 8) (Figure 14A-B and Figure 15A-B).  Location (0-100µm and 
500-600µm) had no effect on the number of active zoospores within the control, 2,4-
Figure 13.  Treatment had no effect on the number of movements a B. dendrobatidis 
(JEL 423) zoospore took either towards (A) the source or away (B) from the source 
among the control and both violacein low and high treatments.  Letters represent 
Tukey groupings and error bars represent standard error. 
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DAPG at low, and I3C treatments (Table 8).  There were more active zoospores at 500-
600µm than at 0-100µm within the 2,4-DAPG high treatment (P = 0.0005) (Table 8) 
(Figure 15B). Locations were pooled for all treatments, including 2,4-DAPG high, since 
the overall trend was for the response variables to not vary as a function of location. 
 
Table 8.  Effect of time and location on B. dendrobatidis (JEL 310) zoospore activity 
within treatments. 
ANOVA 
Effect of time (t = 0 and t = 6 hours)  
Treatment n’s df F Sig. 
Control 10 18 64.21 <0.0001 
2,4-DAPG low 10 18 94.85 <0.0001 
2,4-DAPG high 10 18 21.52 0.0003 
I3C 6 10 40.41 0.0002 
Effect of location 
Treatment n’s df F Sig. 
Control 10 18 0.18 0.6788 
2,4-DAPG low 10 18 1.75 0.2050 
2,4-DAPG high 10 18 21.52 0.0005 
I3C 6 10 0.05 0.8273 
 
 
 Between treatment comparisons 
 The control and 2,4-DAPG low treatments had approximately equal number of 
active zoospores relative to 2,4-DAPG high treatment that had lower numbers of active 
zoospores (P = 0.0005) (Table 9) (Figure 14A-B and Figure 15A).  Treatment had no 
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effect on the number of active zoospores between the control and I3C treatments (Table 
9) (Figure 14A and Figure 15B).  
 
Table 9.  Between treatment comparisons of B. dendrobatidis (JEL 310) zoospore 
activity. 
ANOVA 
Treatments n’s df F Sig. 
Control, 2,4-
DAPG low, & 
2,4-DAPG high 
20 57 8.89 0.0005 
Control & I3C 20, 12 30 0.02 0.8766 
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Figure 14.  Time had an effect on active zoospores within both the control (n’s = 10)  
and 2,4-DAPG low (n’s = 10) (P < 0.0001 and P < 0.0001 respectively) treatments.  
The number of active zoospores was approximately equal for both the control and 2,4-
DAPG low at both time and location. 
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B. dendrobatidis (JEL 423) Zoospore Activity 
 
 Within treatment comparisons  
 Zoospore activity did not change over two times sampled (t = 0 and t = 6 hours) 
within the control, violacein low, and violacein high treatments (Table 10).  Location had 
Figure 15.  Time had an effect on active zoospores within both the 2,4-DAPG high 
(n’s = 10) and I3C (n’s = 6) (P = 0.0003 and P = 0.0002 respectively).  The number of 
active zoospores was less 2,4-DAPG high at both time and location relative to both the 
control and 2,4-DAPG low (n’s = 20) (P = 0.0005).    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no effect on zoospore activity within the control, violacein low, and violacein high 
treatments (Table 10).   
 
Table 10.  Effect of time and location on B. dendrobatidis (JEL 423) zoospore activity 
within treatments. 
ANOVA 
Effect of time (t = 0 and t = 6 hours)  
Treatment n’s df F Sig. 
Control 5 9 0.09 0.7618 
Violacein low 5 9 2.12 0.0782 
Violacein high 5 9 0.06 0.6244 
Effect of location  
Treatment n’s df F Sig. 
Control 5 9 0.09 0.7618 
Violacein low 5 9 2.12 0.1632 
Violacein high 5 9 0.06 0.6244 
 
 
 
Between treatment comparisons 
B. dendrobatidis (JEL 423) zoospore activity did not differ between the control (n 
= 5) and both violacein at low (n = 5) and high (n = 5) concentrations (F = 0.56; DF = 
2,12; P = 0.5760).   
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Mathematical Models (JEL 310) 
The number of movements a zoospore took from the furthest starting position 
(D9) for simulations that took between 9-100 movements to reach the source can be seen 
in Figure 16.  Not all simulations reached the source between 9-100 movements and took 
move movements to reach the source.  The median number of movements to reach the 
source was found for simulations in the control to be 12.1.  The median number of 
movements in the 2,4-DAPG low and 2,4-DAPG high treatments was 39.8 and 42.2 
respectively.  The median number of movements to reach the source in the I3C treatment 
was 32.2. 
 
 
 
Figure 16.  The median number of movements a single B. dendrobatidis (JEL 
310) zoospore took to reach the source for 500 simulations if released at the 
location furthest from the source (D9).  Only simulations that reached the 
source between 9-100 movements are shown. 
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The model to illustrate zoospore dispersal where 200 zoospores are released at D5 
results are shown in Figure 17.  The weighted average is lower in the control compared to 
the other three treatments (2,4-DAPG low, 2,4-DAPG high, and I3C).  Zoospores in the 
three experimental treatments continue to move away from the source as depicted by the 
weighted averages increasing as time steps increase.  Zoospores in the control treatments 
continue to move closer to the source as depicted by the weighted averages decreasing as 
time steps increase. 
 
 
 
 
 
Figure 17.  Average number of B. dendrobatidis (JEL 310) zoospores at 
locations in the model at six different time steps (0, 10, 20, 30, 40, 50). 
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Mathematical Models (JEL 423) 
 The number of movements a zoospore took from the furthest starting position 
(D9) for simulations that took between 9-100 movements to reach the source can be seen 
in Figure 18.  Not all simulations reached the source between 9-100 movements and took 
move movements to reach the source.  The median number of movements simulations 
from the control treatment took was 23.4 movements.  The median number of movements 
from simulations from the violacein low treatment was 54.3.  The median number of 
movements from the violacein high treatment was 32.2. 
 
 
 
 
 
Figure 18.  The median number of movements a single B. dendrobatidis (JEL 423) 
zoospore took to reach the source for 500 simulations if released at the location 
furthest from the source (D9).  Only simulations that reached the source between 9-100 
movements are shown.  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The model to illustrate zoospore dispersal where 200 zoospores are released at D5 
results are shown in Figure 19.  The weighted average is lower in the control and 
violacein high treatments compared to the violacein low treatment.  Zoospores in the 
control and violacein high treatments continue to move towards the source as time steps 
increase.  Zoospores in the violacein low treatment moves away from the source as time 
steps increase.  
 
 
Figure 19.  Average number of B. dendrobatidis (JEL 423) zoospores at locations in the 
model at six different time steps (0, 10, 20, 30, 40, 50).  
 
Discussion 
Amphibian populations that co-exist with B. dendrobatidis do so with sub-lethal 
infections and several co-existing populations have also been identified with higher 
proportions of individuals with anti-B. dendrobatidis skin bacteria (Lam et al. 2010, 
Woodhams et al. 2007b).  Skin bacteria may drive B. dendrobatidis densities down and 
keep densities below a lethality-threshold resulting in sub-lethal infections.  There are 
three hypothesized mechanisms that skin bacteria may use to drive B. dendrobatidis 
densities down: 1) skin bacteria may reduce the number of available attachment sites on 
amphibian skin, 2) antifungal metabolites produced by skin bacteria may directly kill B. 
dendrobatidis, and 3) skin bacteria may alter B. dendrobatidis zoospore behavior 
resulting in chemotaxis away from bacterially-produced antifungal metabolites. 
The results show that zoospores have chemotactic behavior in the presence of two 
bacterially-produced metabolites (2,4-DAPG and I3C).  Zoospores exhibit chemotaxis in 
the presence of keratin suggesting that the pathogen has some ability to locate its 
amphibian host (Moss et al. 2008).  I have now also shown that zoospores show a 
behavioral response to antifungal metabolites that are produced by bacteria isolated from 
amphibian skin.  Zoospores move more frequently away from sources of 2,4-DAPG and 
I3C. 
These results increase support that amphibian skin bacteria play a role in the 
defense against the amphibian disease chytridiomycosis.  More research is needed to 
determine transmission effects of having different proportions of individuals with anti-B. 
dendrobatadis bacteria.  Once an effective proportion of individuals needed to have anti-
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B. dendrobatidis to protect a population is found, using bacteria to bio-augment 
amphibian populations may be a tool for conservational purposes.   
 
B. dendrobatidis Zoospore Movement Patterns 
 Both isolates of B. dendrobatidis zoospores (JEL 310 and JEL 423) had similar 
behavioral patterns of movement in all treatments.  The two most frequent movement 
patterns were circular and oscillations either inward or outward.  Because zoospores 
moved in this way, the method by which I determined differences in the total zoospore 
movement either toward or away from the edge of the source (measuring the initial 
distance a zoospore was from the edge of the agar source and end point distance after ten 
seconds) may not have been an appropriate.  Depending on where the zoospore was 
during its oscillation, total distance traveled might not reflect the general trend moved 
toward or away from a metabolite.  Determining where the zoospore is at its closet point 
to the edge of the source and at its furthest point at the edge of the source would result in 
a better overall measurement of total distance a zoospore moves towards or away from a 
metabolite. 
 
B. dendrobatidis Zoospore Activity and Sampling Time 
 Two sampling times were chosen to be initial time (t = 0 hours) and the time at 
which 50% of B. dendrobatidis (JEL 310) zoospores remained active.  The data show that 
at approximately 6 hours 50% of zoospores from isolate JEL 310 were no longer active.  
Inactivity suggests that the zoospores were beginning to settle from absorbing their 
flagella to transition into their sporangium life stage.  At 24 hours zoosporangium could 
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be seen implicating that these zoospores were not dead.  These results were different for 
isolate 423 where approximately 75% of zoospores were still active at 12 hours.  Finally, 
Piotrowski et al. (2004) observed that B. dendrobatidis isolate JEL 197 showed 
approximately 50% of zoospores were active at 18 hours. 
The difference in zoospore activity between isolates may be a result genetic 
variation, however recent studies have found that there is little variation found among 
isolates (James et al. 2009, Morehouse et al. 2003).  Another explanation for the 
difference in zoospore activity may be the amount of time an isolate is kept in lab after it 
has been isolated from the wild.  Voyles et al. (2009) found that pathogenesis of B. 
dendrobatidis decreased with the amount of time an isolate was kept in the lab.  Isolate 
JEL 310 had been kept in lab approximately a year before it had been used for this 
experiment.  Isolate 423 had only been in the lab for one month before its use and had 
just recently been cultured from -800C.  Continual making of new weekly stocks of B. 
dendrobatidis may select for zoospores that settle more quickly in the broth culture 
relative to newly isolated B. dendrobatidis from amphibians.  Zoospores that settle and 
encyst quickly in broth cultures may have a higher fecundity in lab than in nature.  
Zoospores that remain active longer may have a better chance at survival in nature 
because it allows them more time to search out for susceptible amphibian hosts. 
 
How Amphibian Skin Bacteria May Ameliorate the Effects of Chytridiomycosis 
 Previous research has shown that amphibians with anti-B. dendrobatidis bacteria 
on their skins suffer less morbidity and mortality when infected with B. dendrobatidis 
than amphibians without anti-B. dendrobatidis bacteria (Becker et al. 2009, Harris et al. 
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2006, Harris et al. 2009a, Harris et al. 2009b).  The mechanism(s) of the benefit(s) from 
having anti-B. dendrobatidis bacteria on amphibian skins are not fully known.  It is 
hypothesized that skin bacteria may compete with B. dendrobatidis zoospores for 
attachment sites.  As the density of skin bacteria on an amphibian increases, available 
attachment sites for B. dendrobatidis zoospores may decrease and may drive the density 
of zoospores to stay below the lethal threshold.  It is also hypothesized that skin bacteria 
that produce antifungal compounds that kill B. dendrobatidis may also drive the density 
of zoospores to stay below the lethal threshold by direct mortality.  The concentrations of 
bacterially-produced metabolites are poorly estimated on amphibian skin (Brucker et al. 
2008b), but concentrations are hypothesized to be most likely variable and unevenly 
dispersed on amphibian skin due to the different microenvironments on amphibian skin.  
It is possible that with large densities of skin bacteria that produce anti-B. dendrobatidis 
metabolites there may be large enough concentrations of the metabolites in many areas 
dispersed evenly on amphibian skin to cause enough direct mortality of B. dendrobatidis 
to drive the density of zoospores below the lethal threshold.  An additional hypothesis 
may be B. dendrobatidis zoospores avoid bacterially-produced metabolites at low 
concentrations and that the zoospores ability to move away from the metabolites is what 
drives the zoospore density below lethal threshold. 
 
B. dendrobatidis (JEL 310) Chemotaxis in the Presence of Bacterially-Produced 
Metabolites 
 B. dendrobatidis (JEL 310) show chemotaxis in the presence of 2,4-DAPG at low 
and high concentration and I3C at high concentration.  Both of these metabolites have 
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been shown to be anti-B. dendrobatidis in inhibition assays in vitro.  The metabolite 2,4-
DAPG is a known metabolite produced by several Pseudomonas species (Weller et al. 
2007) and was also identified from Lysobacter gummosus isolated from the eastern red-
backed salamander, Plethodon cinereus (Brucker et al. 2008a, Harris et al. 2006).  Many 
different species of Pseudomonas have been isolated from amphibians and have shown 
antifungal properties, but metabolites have not been identified (Harris et al. 2006, Lam et 
al. 2010, Lauer et al. 2007, Lauer et al. 2008, Woodhams et al. 2007b).  The metabolite 
I3C was identified from Janthobacterium lividum (Brucker et al. 2008b) and this bacteria 
species has been identified on several amphibians (Harris et al. 2006, Lauer et al. 2007, 
Lam et al. 2010, Woodhams et al. 2007b).  Identification for these metabolites on 
amphibian skin has not been researched. 
Zoospores move more frequently toward a source containing no metabolite than 
from a source containing either 2,4-DAPG at low and high concentration or I3C at high 
concentration.  Likewise, zoospores also moved more frequently away from a source 
containing a metabolite than a source containing no metabolite.  These data suggest that 
not only do zoospores have chemotaxis in the presence of these metabolites, but also that 
overall zoospore movement is away from the metabolites.  Additional observations 
indicated that zoospores were concentrated at the farthest distance from the metabolite 
source, which supports this conclusion.   
 It is hypothesized that metabolites would form a concentration gradient from the 
source containing the metabolite and the furthest location away from the metabolite in 
solution.  However, location had no effect on zoospore movement either towards the 
metabolite or away from the metabolite for the control, 2,4-DAPG low and I3C high 
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treatments.  This may be due to the small volume of Provosoli that each chamber held.  In 
the future concentration gradients should be measured.  If the chambers do not represent 
a concentration gradient then it is likely that if the chambers were made to be longer and 
measurements taken further from the source then the effect of location may have be seen.  
However, casual observations showed that zoospore density was highest at the far edge of 
the chamber away from the metabolite.  In addition, it is likely that a gradient was present 
at t = 0 and behavior was the same six hours later.  This observation also suggests a 
gradient established.  These observations, along with the bulk of the chemotaxis data, 
suggest that a concentration gradient was established. 
The metabolite 2,4-DAPG at high concentration did show an effect of location on 
zoospore movement both towards the metabolite and away from the metabolite.  
Zoospores moved towards 2,4-DAPG high more frequently further away from the 
metabolite and moved less frequently away from the metabolite as distance increased.  It 
is possible that at the high concentration of 2,4-DAPG there may have been deleterious 
effects on the zoospores that cause their movement to be erratic. 
 
B. dendrobatidis (JEL 423) Showed No Chemotaxis in the Presence of Bacterially-
Produced Violacein 
 B. dendrobatidis isolate JEL 423 showed no chemotaxis in the presence of 
violacein at either low or high concentration.  There are several explanations for this that 
need further investigation.  One explanation may be that there is variation between the 
two isolates (JEL 310 and 423) either due to genetic variation or due to variation in their 
pathogenesis and behavior based on number of generations in the laboratory.  If JEL 423 
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has a higher pathogenesis than JEL 310 it could explain why JEL 423 showed no 
chemotaxis in the presence of violacein.  Behavior can be a part of determining the 
pathogenesis for an organism.  Perhaps one factor making isolates highly pathogenic is 
due to the isolates ability to withstand bacterially-produced metabolites such as violacein.  
Another explanation for why JEL 423 showed no chemotaxis in the presence of violacein 
may be due to the metabolites insolubility in Provosoli medium.  Repeating this 
experiment again with 1% dimethyl sulfoxide (DMSO) in addition to the Provosoli 
medium may allow for the metabolite to form a concentration gradient and may change 
the chemotaxis of zoospores in the presence of violacein.  However, this brings about the 
question of how likely is this in nature?  If violacein is insoluble in Provosoli medium 
than does it form a concentration gradient in the mucus layer it is found it?  One 
possibility is that Janthinobacterium lividum that produces violacein (Brucker et al. 
2008b) also secretes a molecule that makes the violacein soluble.  More research is 
necessary to fully understand the mechanism(s) that insoluble bacterially-produced 
metabolites use to ameliorate chytridiomycosis. 
 
B. dendrobatidis (JEL 310) Zoospore Activity in the Presence of Bacterially-Produced 
Metabolites 
 There were more active zoospores at t = 0 hours than at t = 6 hours within the 
control and all three of the treatments (2,4-DAPG low, 2,4-DAPG high, and I3C high).  
This is not surprising considering that 50% of the zoospores (JEL 310) are no longer 
active at 6 hours and this likely contributes to the effect of time.  Location had no effect 
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on active zoospores for within all treatments with the exception of 2,4-DAPG at high 
concentration. 
The control and 2,4-DAPG treatments had similar numbers of active zoospores 
than the 2,4-DAPG high treatment.  This result may have been due to direct mortality of a 
proportion of zoospores exposed to a high concentration of 2,4-DAPG.  There was no 
effect of treatment on the number of active zoospores at two locations sampled between 
the control and I3C at high concentration.  
 
B. dendrobatidis (JEL 423) Zoospore Activity in the Presence of Violacein 
 There was no significant effect of treatment on B. dendrobatidis (JEL 423) 
zoospore activity between the control and both violacein at low and high concentrations.  
Explanations for this are similar to the explanations to explain why there were no effects 
of violacein on zoospore movement towards or away from the source. 
 
B. dendrobatidis (JEL 310) Zoospores Take Longer to Reach the Source and Are Less 
Likely to Distribute on The Source in the Presence of Bacterially-Produced Metabolites 
 Using parameters estimated from data collected on zoospore movement, it was 
observed that when a single zoospore was released from the middle of the model (D5) it 
reached the source more quickly in the control than the three treatments (2,4-DAPG low, 
2,4-DAPG high, and I3C).  This suggests that if zoospores were released into the 
environment they would reach amphibians without bacterially-produced metabolites 
more quickly than amphibians with bacterially-produced metabolites. 
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 The model to illustrate the transmission of 200 zoospores that are released in the 
furthest location of the model (D9) shows that as time increases zoospores move in 
locations further away from the source in all experimental treatments.  Zoospores in the 
control treatment move towards locations closer to the source as time increases.  This 
suggests that if zoospores are released into the environment that amphibians that have 
bacterially-produced metabolites on their skins would have a lower proportion of 
zoospores that infect the amphibian than those that do not have bacterially-produced 
metabolites on their skins. 
 This model also illustrates that zoospores released from sporangia located on frog 
skin that also have antifungal metabolites will leave the frog skin and this may drive 
zoospore density to remain below the lethal-threshold and also increase transmission to 
susceptible amphibians.  In the presence of no metabolite, zoospores released from 
sporangia located on amphibian skin are more likely to remain on frog skin and re-
infecting the amphibian.  This could drive exponential growth of zoospores on amphibian 
skin and quickly surpass lethal-threshold.   
 
B. dendrobatidis (JEL 423) Zoospores Are Equally Likely to Reach the Source and 
Are Less Likely to Distribute on the Source in the Presence of Violacein at Low 
Concentrations 
 The model predicts that more zoospores will take longer to reach the source in the 
violacein low treatment compared to the control and violacein high treatment.  This 
suggests that if an amphibian has low concentrations of violacein on its skin, zoospores 
will take longer to reach the amphibian.  
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 The model to illustrate the transmission of 200 zoospores that are released in the 
middle of the model (D5) shows that as time increases zoospores move in locations 
further away from the source in the violacein low treatment.  Zoospores in the control  
and violacein high treatments first move away from the source and then gradually move 
closer towards the source.  This suggests that if zoospores are released into the 
environment that amphibians that have violacein in low concentrations on their skins 
would have a lower proportion of zoospores that infect the amphibian than those that do 
not have violacein or have violacein at high concentrations on their skins. 
 
Conclusion 
 The results of this study show that B. dendrobatidis zoospores show chemotaxis 
in the presence of two bacterially-produced metabolites and that zoospores are less likely 
to distribute onto a source containing metabolites than a source that does not have 
metabolites.  Chemotaxis of zoospores in the presence of metabolites may be a 
mechanism driving and maintaining zoospore density on frog skin to stay below the 
lethal threshold.  Skin bacteria that produce anti-B. dendrobatidis metabolites may 
ameliorate the effects of chytridiomycosis on amphibians that host them.  These 
amphibians may also co-exist with B. dendrobatidis even if sporangia are found on their 
skins if sporangia are found at very low numbers. 
 Understanding all of the components of the amphibian innate immune system and 
defenses and how the interactions between the components protect amphibians from 
diseases such as chytridiomycosis needs more research.  Future research should focus on 
synergistic or antagonistic relationships between amphibian skin bacteria and amphibian 
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produced AMPs.  Identifying population density and distributions of skin bacteria on 
amphibian skin in different microenvironments is needed to infer how effective 
bacterially defenses are.  There is need to understand how zoospores move in pond water 
compared to the mucus on the amphibian skin.  Also needed is a determination of the 
most effective concentration of metabolites needed to produce the maximal effects of bio-
augmentation.  Results of I3C and violacein at high concentration suggest that these 
metabolites may be more effective at lower concentrations to encourage the smallest 
proportion of zoospores to disperse to frog skin.  For conservation purposes, bio-
augmentation of amphibian skin with too much bacteria may be costly for the host to 
maintain or may cause disease as many commensal bacteria are shown to do at high 
densities.  However, bio-augmentation of amphibian skin bacteria with an appropriate 
number of bacteria may have the desired effects of ameliorating chytridiomycosis 
without any cost to the amphibian.  
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